4min chapter

The HemOnc Pulse cover image

‘The HemOnc Pulse’ Live: Unanswered Questions in T-Cell Lymphoma

The HemOnc Pulse

CHAPTER

Exploring JAK Inhibitors for T-Cell Lymphoma

Discussion on the potential efficacy of JAK inhibitors beyond Ruxolitinib in treating T-cell lymphoma, highlighting their role in induction and maintenance for T lymphomas. Challenges in studying rare subtypes of T-cell lymphoma and comparison of drug effectiveness in T-cell lymphoma versus myeloproliferative neoplasms are also covered.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode